Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Spain Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20062
20074
20084
20095
20102
20115
20127
20138
20146
20156
20164
20173
20183
20197
202010
20214
20222
20235
20243
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated20
Active, not recruiting12
Recruiting6
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Amgen4
Grupo Español Multidisciplinar de Melanoma4
MedSIR4
Novartis Pharmaceuticals4
Bristol-Myers Squibb3
Daiichi Sankyo3
Grupo Espanol de Investigacion en Sarcomas3
Spanish Oncology Genito-Urinary Group3
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis101
Breast Neoplasms23
Neoplasms18
Colorectal Neoplasms15
Carcinoma, Non-Small-Cell Lung13
Recurrence12
Colonic Neoplasms6
Lung Neoplasms6
Carcinoma, Transitional Cell5
Rectal Neoplasms5

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.